Testing alerts to help doctors prescribe aspirin for pregnancy safety
Part of Women’s health & pregnancy clinical trials.
This trial tests whether sending reminders to doctors helps them prescribe low-dose aspirin to pregnant patients at higher risk of preeclampsia (a serious pregnancy condition). Aspirin early in pregnancy may help prevent preeclampsia if you have risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant, between 12 and 28 weeks along
- You are 18 years old or older
- Your doctor has identified you as having a higher-than-average risk for preeclampsia based on current medical guidelines
- You receive regular prenatal care at one of the trial's partnering hospitals or clinics
- You do not have a documented reason in your medical record that makes aspirin unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.
This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.
This trial tests whether stopping aspirin use in high-risk pregnant women can be safe. It aims to find the best time to stop taking aspirin to prevent preeclampsia, a condition that causes high blood pressure during pregnancy.
This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.